Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

chemotherapy and radiotherapy in Patients with inflammatory breast cancer.

ejection fraction
epirubicin
trastuzumab
cyclophosphamide
neutrophil count
  • 13 views
  • 07 Nov, 2020
  • 1 location
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer

This phase II multicentre randomized open-label study will assess the safety and efficacy of Pembrolizumab in combination with standard chemotherapy in inflammatory breast cancer. Pembrolizumab

erythema
paclitaxel
edema
ejection fraction
peau d'orange
  • 7 views
  • 09 Jul, 2020
  • 22 locations
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC). The Following drugs will be use in combination with Ruxolinitinib.

ruxolitinib
paclitaxel
cytoxan
doxorubicin
immunohistochemistry
  • 0 views
  • 06 Aug, 2020
  • 8 locations
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer. Radiation therapy uses high energy x-rays to kill

hormone therapy
olaparib
ischemia
erbb2
renal function
  • 45 views
  • 18 Jan, 2021
  • 124 locations
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

This research study is studying a drug called eribulin combined with standard treatment as a possible preoperative treatment for HER2 negative inflammatory breast cancer.

probe
HER2
invasive breast cancer
cyclophosphamide
neutrophil count
  • 0 views
  • 10 Sep, 2020
  • 1 location
Atezolizumab Cobimetinib and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

This phase II trial studies how well atezolizumab, cobimetinib, and eribulin work in treating patients with inflammatory breast cancer that has spread to other places in the body. Immunotherapy

cobimetinib
breast cancer
serum bilirubin level
gilbert disease
tumor cells
  • 1 views
  • 13 Dec, 2020
  • 2 locations
Pembrolizumab in Treating Patients With Hormone Receptor Positive Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

This phase II trial studies how well pembrolizumab works in treating patients with hormone receptor positive inflammatory breast cancer that has not spread to other parts of the body, who are

monoclonal antibody therapy
hormone therapy
erbb2
monoclonal antibodies
endocrine therapy
  • 66 views
  • 17 Jan, 2021
  • 2 locations
Dose-escalation Study of Oral CX-4945

This Phase 1 study of oral CX-4945 is designed to test the safety, tolerability and highest safe dose level of this CK2 inhibitor in patients with advanced solid tumor cancers, Castleman's Disease or Multiple Myeloma.

platelet count
hormone therapy
inflammatory breast cancer
cancer
endocrine therapy
  • 38 views
  • 07 Nov, 2020
  • 1 location
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

This trial will compare the administration of 2 cycles of paclitaxel and cisplatin (DP) versus 4 cycles of CEF as adjuvant chemotherapy for the patients with locally advanced breast cancer and who were pathological partial response to DP as neoadjuvant chemotherapy. Those who had pathological complete response to DP will …

hormone therapy
advanced breast cancer
breast cancer
endocrine therapy
locally advanced breast cancer
  • 1 views
  • 29 Mar, 2020
  • 1 location
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

This phase I/II trial studies the side effect and best dose of neratinib and to see how well it works with paclitaxel and with or without pertuzumab and trastuzumab before combination chemotherapy in treating patients with breast cancer that has spread to other places in the body. Neratinib may stop …

probe
breast surgery
paclitaxel
advanced breast cancer
local therapy
  • 12 views
  • 17 Jan, 2021
  • 2 locations